Versor Investments LP
CIK 0001650301 · NEW YORK, NY · Quarter end: 2026-06-30 · Filed on: 2026-08-07 · Open the SEC source ↗
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$47.5M
2026 Q2
Positions
27
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
55.7%
Est. Net Flow (Q)
—
2026 Q2
Top Holdings
670703107
NUVALENT INC
6.7%
G4474Y214
JANUS HENDERSON GROUP PLC
6.4%
TECH
BIO-TECHNE CORP
6.3%
NSC
NORFOLK SOUTHN CORP
5.6%
81619Q105
SELECT MED HLDGS CORP
5.6%
87427V103
TALKSPACE INC
5.2%
03770N101
APOGEE THERAPEUTICS INC
5.1%
14888U101
CATALYST PHARMACEUTICALS INC
5.0%
New / Increased
No prior quarter data
Reduced / Exited
No prior quarter data
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.